Cardica finishes $10M private placement

ONLINE: home | business news | small business | sales & marketing | real estate | events | community | careers | city guide | advertise | about us | rss PRINT: subscribe | renew | advertise | book of lists | business intelligence | ...
Click here to read the whole Article (external link)

Q1 2010 CARDICA INC Earnings Release - After Market Close

Earnings Announcements for Thursday, October 29CompanySymbolTimeConferenceCall3PAR Inc.PARAfter Market CloseListenABBABB01:00 am ETABG SUN COL HLDGASC.OLTime Not SuppliedAccuray IncorporatedARAYAfter Market CloseListenACHENG RELAY000922.SZTime Not SuppliedAcme Packet, Inc.APKTAfter Market CloseListenAcme UnitedACU09:00 am ETListenACS, Actividades de Construcción y Servicios, S.A.ACS.MCAfter Market CloseACTELIOSACT.MI10:00 am ETActuate CorporationACTUAfter Market CloseListenAdaptec, Inc.ADPTTime Not SuppliedListenAdolor CorporationADLRTime Not SuppliedListenADVA Optical NetworkingADV.FTime Not SuppliedListenAetna Inc.AETBefore Market OpenListenAGL ResourcesAGLBefore Market OpenListenAgree Realty...
Click here to read the whole Article (external link)

Cardica to Announce Fiscal 2009 First Quarter Financial Results on Thursday, October 29, 2009

REDWOOD CITY, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC - News) today announced that it will release financial results for its fiscal first quarter ended September 30, 2009, on Thursday, October 29, 2009, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business. Conference Call DetailsTo access the live conference call on October 29, 2009, at 4:30 p.m. Eastern Time via phone, please dial 866-713-8562 from the United States and Canada or 617-597-5310 internationally. The conference ID is 91147635. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 5, 2009, and may be accessed by dialing 888-286-8010 from the United States and Canada or 617-801-6888 internationally. The replay passcode is 59062423.To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of Cardica's website at www.cardica.com. Please connect to the website at least 15 minutes prior to the call to allow for any necessary software downloads.The webcast is also being distributed through the Thomson StreetEvents Network. Individ...
Click here to read the whole Article (external link)

CARDICA INC Files SEC form 8-K, Other Events

Item 8.01. Other Events. On May 22, 2009, Cardica, Inc. (the "Company") announced that it received a letter, dated May 19, 2009, from the Listing Qualifications Department of The NASDAQ Stock Market notifying the Company that it did not comply with the $10.0 million minimum stockholders' equity requirement for continued listing on The NASDAQ Global Market set forth in NASDAQ Marketplace Rule 5450(b)(1)(A). NASDAQ's determination was based on a review of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2009. As provided in the NASDAQ rules, the Company timely submitted to the NASDAQ Staff a plan to continue listing on The NASDAQ Global Market. NASDAQ granted the Company an extension until September 1, 2009, to regain compliance with the listing standards. On September 2, 2009, the Company received a second letter from the Listing Qualifications Department of The NASDAQ Stock Market notifying the Company of its determination that the Company had failed to meet the terms of the extension because the Company failed to publicly disclose a compliant stockholders' equity balance by September 1, 2009. Pursuant to the NASDAQ rules, the Company may either apply for listing on The NASDAQ Capital Market, provided it meets the continued listing requirements of that market, or appeal the decision to a NASDAQ Listing Qualifications Panel. The Company requested a hearing to appeal the decision, and the Company's securities will remain listed on The NASDAQ Global Market pending a decision by the Panel following the hearing. The hearing was set for October 15, 2009. On September 30, 2009 (the "Issuance Date"), the Company issued an aggregate of 8,142,082 shares of common stock and warrants to purchase up to 4,071,046 shares of common stock for aggregate gross proceeds of approximately $10,200,000 (the "Private Placement"). The Private Placement was issued and sold pursuant to a Securities Purchase Agreement, dated September 25, 2009, between the ...
Click here to read the whole Article (external link)

Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress

REDWOOD CITY, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC - News) today reported financial results for its fiscal 2010 first quarter ended September 30, 2009. Our financial results reflect a transition of our sales model related to our automated anastomotic systems used by cardiac surgeons to perform coronary bypass surgery and the expansion of our business through the development of an endoscopic microcutter intended for use by general, thoracic, gynecologic, bariatric and urologic surgeons. "During the first quarter of fiscal 2010, we signed six new agreements with independent distributors and manufacturers' representatives, bringing our external sales team to 22. We utilized the summer months, during which typically there are fewer cardiac surgery procedures, to train our new sales representatives, preparing them to proctor bypass procedures using our automated anastomosis products moving forward. While our revised sales model using a core sales team supported by independent distributors and manufacturers' representatives remains to be proven, we believe that it will allow us to incrementally increase clinician adoption of our cardiac surgery products while controlling our costs," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica."In addition, we completed a private placement that provided funding for the further development of the Cardica Microcutter, which applies our proprietary automated stapling technology outside of cardiac surgery and has potential use in...
Click here to read the whole Article (external link)

CARDICA INC Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

CARDICA INC Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This report includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. All statements other than statements of historical facts are "forward-looking statements" for purposes of these provisions, including any projections of earnings, revenue or other financial items, any statement of the plans and objectives of management for future operations, any statements concerning proposed new products or licensing or collaborative arrangements, any statements regarding future economic conditions or performance, and any statement of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as "may," "will," "expects," "plans," "anticipates," "estimates," "potential," or "continue" or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, including but not limited to the risk factors set forth in Item 1A below, and for the reasons described elsewhere in this report. All forward-looking statements and reasons why results may differ included in this report are made as of the date hereof, and we assume no obligation to update these forward-looking statements or reasons why actual results might differ. Overview ...
Click here to read the whole Article (external link)

CARDICA INC Earnings Call scheduled for 4:30 pm ET today

Call DetailsCARDICA INC Earnings Conference Call (Q1 2010)Thu, Oct 29, 2009, 4:30 pm EasternAbout CARDICA INC (NasdaqGM:CRDC)Cardica, Inc. designs, manufactures, and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery. The company’s products include C-Port Distal Anastomosis System, which is designed to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis System that includes modifications to the C-Port xA system designed to enable automated anastomoses to be performed as part of minimally invasive and robot-facilitated CABG procedures; and C-Port X-CHANGE system, a cartridge-based reloadable C-Port system. Its products also comprise PAS-Port Proximal Anastomosis System, an automated device used to perform an end-to-side proximal anastomosis between a saphenous vein and the aorta. In addition, the company develops the Cook Vascular Closure Device to be used in interventional vascular procedures; and Cardica Microcutter, an endoscopic microcutter intended for use by general, thoracic, gynecologic, bariatric, and urologic surgeons. Cardica primarily sells the C-Port systems in the United States and Europe, and the PAS-Port systems in the United States, Europe, and Japan through distributors. It has a collaboration agreement with Cook Incorporated to develop Patent Foramen Ovale Closure Device that is designed to close holes in the heart from genetic heart defects known as patent foramen ovales. The company was formerly known as Vascular Innovations, Inc. and changed its name to Cardica, Inc. in November 2001. The company was founded in 1997 and is based in Redwood City, California.More Info:Quote |...
Click here to read the whole Article (external link)

CARDICA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits

Show all filings for CARDICA INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for CARDICA INC 29-Oct-2009Results of Operations and Financial Condition, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" ...
Click here to read the whole Article (external link)

CARDICA INC Files SEC form 8-K, Change in Directors or Principal Officers

Show all filings for CARDICA INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for CARDICA INC 13-Nov-2009Change in Directors or Principal Officers Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended...
Click here to read the whole Article (external link)